Why TCRT? Alaunos Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
TCRT
$2.61+0.06 (+2.35%)
Market ClosedLast close May 1
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.